Acute pancreatitis in a patient treated with imatinib and gefitinib.

IntroductionUse of oral antineoplastic agents (OAAs) has increased significantly in recent years. OAAs currently represent 30-50% of all cancer treatments. Drug interactions are the most frequent d...